File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Conference Paper: Standard clarithromycin-based triple therapy is superior to levofloxacin-based triple therapy as first-line treatment for Helicobacter pylori eradication in a Chinese population

TitleStandard clarithromycin-based triple therapy is superior to levofloxacin-based triple therapy as first-line treatment for Helicobacter pylori eradication in a Chinese population
Authors
Hung, IFNChan , PHsu, ABut, DYKSeto, WKWChan, CKWong, SYTong, TWong, BCY
Issue Date2009
PublisherAmerican Gastroenterological Association. The Journal's web site is located at http://www.elsevier.com/locate/gastro
Citation
The 2009 Digestive Disease Week (DDW), Chicago, IL., 30 May- 4 June 2009. In Gastroenterology, 2009, v. 136 n. 5 suppl. 1, p. A-150 How to Cite?
DOI: http://dx.doi.org/10.1016/S0016-5085(09)60004-4
DescriptionAGA Abstract No. 978
Persistent Identifierhttp://hdl.handle.net/10722/62299
ISSN
0016-5085
2023 Impact Factor: 25.7
2023 SCImago Journal Rankings: 7.362

 

DC FieldValueLanguage
dc.contributor.authorHung, IFNen_HK
dc.contributor.authorChan , Pen_HK
dc.contributor.authorHsu, A-
dc.contributor.authorBut, DYK-
dc.contributor.authorSeto, WKW-
dc.contributor.authorChan, CK-
dc.contributor.authorWong, SY-
dc.contributor.authorTong, T-
dc.contributor.authorWong, BCY-
dc.date.accessioned2010-07-13T03:58:17Z-
dc.date.available2010-07-13T03:58:17Z-
dc.date.issued2009en_HK
dc.identifier.citationThe 2009 Digestive Disease Week (DDW), Chicago, IL., 30 May- 4 June 2009. In Gastroenterology, 2009, v. 136 n. 5 suppl. 1, p. A-150-
dc.identifier.issn0016-5085-
dc.identifier.urihttp://hdl.handle.net/10722/62299-
dc.descriptionAGA Abstract No. 978en_HK
dc.languageengen_HK
dc.publisherAmerican Gastroenterological Association. The Journal's web site is located at http://www.elsevier.com/locate/gastro-
dc.relation.ispartofGastroenterology-
dc.titleStandard clarithromycin-based triple therapy is superior to levofloxacin-based triple therapy as first-line treatment for Helicobacter pylori eradication in a Chinese populationen_HK
dc.typeConference_Paperen_HK
dc.identifier.emailHung, IFN: ifnhung@yahoo.com.hken_HK
dc.identifier.authoritySeto, WKW=rp01659en_HK
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1016/S0016-5085(09)60004-4-
dc.identifier.hkuros161495en_HK
dc.identifier.volume136-
dc.identifier.issue5 suppl. 1-
dc.identifier.spageA-150-
dc.identifier.epageA-150-
dc.publisher.placeUnited States-
dc.identifier.issnl0016-5085-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats